Profound Medical Corp. filed a Form 8-K on November 5, 2026, disclosing that it issued a press release announcing financial results for the quarter ended September 30, 2026, along with a business update.

Key Highlights

  • Reporting period: Financial results cover the quarter ended September 30, 2026.
  • Filing date: The current report was filed and dated November 5, 2026.
  • Exchange listing: Profound Medical Corp. common shares trade on The Nasdaq Stock Market under the symbol PROF (NASDAQ:PROF).
  • Press release furnished: A copy of the press release dated November 5, 2026 is furnished as Exhibit 99.1.
  • Signing officer: The report was signed by Arun Menawat, Chief Executive Officer and Chairman.
  • Registrant domicile: Profound Medical Corp. is incorporated in Ontario, Canada, with principal offices at 2400 Skymark Avenue, Unit 6, Mississauga, Ontario, Canada L4W 5K5.

Profound Medical Corp. Files 8-K Covering Third-Quarter 2026 Operations

Profound Medical Corp., a company incorporated in Ontario, Canada, and listed on The Nasdaq Stock Market under the ticker PROF, filed a current report on Form 8-K on November 5, 2026. According to the filing, the company issued a press release on that same date announcing its financial results for the quarter ended September 30, 2026 and providing a business update. The press release is included in the filing as a furnished exhibit, designated Exhibit 99.1.

The filing was made under Item 2.02, Results of Operations and Financial Condition, of the Form 8-K framework. The company disclosed that the information furnished under Item 2.02, including Exhibit 99.1, "shall not be deemed to be 'filed' for purposes of Section 18, of the Securities Exchange Act of 1934, as amended," and is not incorporated by reference into any registration statement or other document unless expressly specified. This characterization is the company's own, as stated in the filing.

The report was signed on behalf of Profound Medical Corp. by Arun Menawat, identified in the filing as Chief Executive Officer and Chairman. The registrant's Commission File Number is 001-39032. The company's common shares are described as having no par value per share. No specific financial figures from the quarterly results appear in the body of the 8-K itself, as the detailed results are contained within the furnished press release, Exhibit 99.1.

What Was Disclosed

Profound Medical Corp. filed a current report disclosing that it announced quarterly financial results for the period ended September 30, 2026. The press release containing those results was furnished as Exhibit 99.1, dated November 5, 2026, and signed by CEO and Chairman Arun Menawat.